Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China
· Delayed Price · Currency is CNY 21.01
-1.09 (-4.93%)
Apr 29, 2026, 2:45 PM CST
Hybio Pharmaceutical Revenue
In the year 2025, Hybio Pharmaceutical had annual revenue of 966.35M CNY with 63.73% growth. Hybio Pharmaceutical had revenue of 283.23M in the quarter ending December 31, 2025, with 31.75% growth.
Revenue
966.35M
Revenue Growth
+63.73%
P/S Ratio
21.73
Revenue / Employee
867.73K
Employees
1,035
Market Cap
19.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 966.35M | 376.15M | 63.73% |
| Dec 31, 2024 | 590.20M | 158.81M | 36.82% |
| Dec 31, 2023 | 431.38M | -272.94M | -38.75% |
| Jan 1, 2023 | 704.32M | -31.65M | -4.30% |
| Jan 1, 2022 | 735.97M | 14.25M | 1.97% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jan 1, 2019 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wedge Industrial | 1.32B |
| Joincare Pharmaceutical Group Industry | 14.85B |
| Walvax Biotechnology | 2.42B |
| Betta Pharmaceuticals | 3.73B |
| Jilin Aodong Pharmaceutical Group | 2.34B |
| Tonghua Dongbao Pharmaceutical | 2.95B |
| Apeloa Pharmaceutical Co.,Ltd | 9.50B |
| China Resources Double-Crane Pharmaceutical | 10.73B |